Flagship Ventures 2007 General Partner’s Agios Pharmaceuticals AGIO Stock Holding History

Flagship Ventures 2007 General Partner’s Portfolio AGIO Stock Details AGIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	$80.9M	Buy	+1,930,369	New	+$95.3M	75.24%	1
2015 Q4	$125M	Hold	1,930,369	–	–	82.23%	1
2015 Q3	$136M	Hold	1,930,369	–	–	85.66%	1
2015 Q2	$215M	Hold	1,930,369	–	–	87.15%	1
2015 Q1	$182M	Hold	1,930,369	–	–	90.41%	1
2014 Q4	$216M	Hold	1,930,369	–	–	89.87%	1
2014 Q3	$118M	Hold	1,930,369	–	–	83.56%	1
2014 Q2	$88.5M	Sell	1,930,369 -1,930,369	-50%	-$78.7M	75.54%	1
2014 Q1	$151M	Hold	3,860,738	–	–	66.31%	1
2013 Q4	$92.5M	Buy	+3,860,738	New	+$88M	58.97%	1

Other funds holding AGIO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Flagship Ventures 2007 General Partner's AGIO Position: Q2 2016 in Review

Flagship Ventures 2007 General Partner opened a new position in Agios Pharmaceuticals (AGIO) in Q2 2016: 1,930,369 shares worth $80.9M. The stake represents 75.24% of the portfolio and ranks #1 among its holdings. This is a return to the name: Flagship Ventures 2007 General Partner previously reported a position in AGIO as recently as Q4 2015.

Flagship Ventures 2007 General Partner first reported a position in AGIO in Q4 2013 and has held it in 10 quarters since. The position peaked at $216M in Q4 2014. 155 funds tracked by Wall St. Rank hold AGIO as of Q2 2016.

Flagship Ventures 2007 General Partner held 1,930,369 shares of Agios Pharmaceuticals worth $80.9M as of Q2 2016.
Agios Pharmaceuticals was a new Flagship Ventures 2007 General Partner position in Q2 2016.
Agios Pharmaceuticals made up 75.24% of Flagship Ventures 2007 General Partner's portfolio in Q2 2016, its #1 holding.
Flagship Ventures 2007 General Partner first reported a position in Agios Pharmaceuticals in Q4 2013 and has held it in 10 quarters since.
Flagship Ventures 2007 General Partner's Agios Pharmaceuticals position peaked at $216M in Q4 2014.
155 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2016.

Based on Flagship Ventures 2007 General Partner's 13F filing for Q2 2016, filed 15 Aug 2016.